Rare diseases - 2/4

by in

Entry	Author	Date	Location
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area	Ryan McBride	09/01/10	Boston
Taligen Collects $10M For Focus on Rare Diseases	Ryan McBride	08/23/10	Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis?	Ryan McBride	07/29/10	Boston
How Much Would You Pay for Genzyme?	Ryan McBride	07/26/10	Boston
Genzyme Gets FDA Nod for Pompe Drug	Ryan McBride	05/25/10	Boston
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston	Ryan McBride	04/12/10	Boston
Page 2 of 2	« previous page

Xconomy National